MVA-BN smallpox vaccine
Term · Oncology and biomedicine · MLC-T-ONC-015379
A vaccine consisting of modified vaccinia Ankara-Bavarian Nordic (MVA-BN), a live, attenuated, non-replicating, proprietary version of the MVA virus, used for the prevention of smallpox and monkeypox, with potential antineoplastic activity. Upon intratumoral administration, MVA-BN smallpox vaccine may induce both cellular and humoral immune responses, which may lead to tumor cell lysis.
| Identifier | MLC-T-ONC-015379 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | modified vaccinia Ankara - Bavarian Nordic smallpox vaccine; modified vaccinia Ankara smallpox vaccine; MVA smallpox vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015379",
"term": "MVA-BN smallpox vaccine",
"field": "Oncology and biomedicine",
"definition": "A vaccine consisting of modified vaccinia Ankara-Bavarian Nordic (MVA-BN), a live, attenuated, non-replicating, proprietary version of the MVA virus, used for the prevention of smallpox and monkeypox, with potential antineoplastic activity. Upon intratumoral administration, MVA-BN smallpox vaccine may induce both cellular and humoral immune responses, which may lead to tumor cell lysis.",
"synonyms": [
"modified vaccinia Ankara - Bavarian Nordic smallpox vaccine",
"modified vaccinia Ankara smallpox vaccine",
"MVA smallpox vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/mva-bn-smallpox-vaccine/"
}
Record 11,474 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.